UnknownPhase 3

Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis

60 participantsStarted 2021-03

Plain-language summary

the study is to evaluate the possible efficacy and safety of nitazoxanide as an adjuvant therapy in the secondary prevention of SBP in patient with cirrhosis.

Who can participate

Age range21 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 21 - 65 years old with cirrhosis and ascites who had at least one previous confirmed episode of spontaneous bacterial peritonitis. Exclusion Criteria: * Exclusion criteria included active gastrointestinal bleeding Hepatic encephalopathy (\>grade 2) Hepatocellular carcinoma (HCC) or other malignancies Allergy to used medications.

What they're measuring

Prevention of Secondary Spontaneous Bacterial Peritonitis

Timeframe: 3 months

Trial details

NCT IDNCT04746937

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03

Contact for this trial

eslam M. Altaras

00201010730130 PG_88188@pharm.tanta.edu.eg

View on ClinicalTrials.gov More Spontaneous Bacterial Peritonitis trials